background
elev
serum
creactiv
protein
crp
level
observ
patient
method
data
patient
clinic
outcom
design
hospit
wuhan
china
retrospect
collect
analyz
jan
feb
prognost
valu
admiss
crp
evalu
patient
patient
enrol
die
recov
nonsurvivor
tend
male
old
age
chronic
diseas
compar
survivor
nonsurvivor
show
significantli
elev
white
blood
cell
neutrophil
count
neutrophil
lymphocyt
ratio
nlr
system
immuneinflamm
index
sii
defin
platelet
count
multipli
nlr
crp
procalcitonin
ddimer
decreas
red
blood
cell
lymphocyt
platelet
count
age
neutrophil
count
platelet
count
crp
identifi
independ
predictor
advers
outcom
area
receiv
oper
characterist
roc
curv
auc
crp
significantli
higher
age
neutrophil
count
platelet
count
outcom
predict
p
cutoff
valu
crp
exhibit
sensit
specif
posit
predict
valu
neg
predict
valu
subgroup
analysi
reveal
crp
remain
robust
accuraci
advers
outcom
predict
patient
differ
diseas
sever
auc
p
auc
p
crp
also
independ
discrimin
severecrit
ill
admiss
auc
p
patient
admiss
crp
correl
diseas
sever
tend
good
predictor
advers
outcom
sinc
first
case
novel
coronaviru
pneumonia
latterli
name
world
health
organ
report
wuhan
decemb
infect
patient
caus
death
china
newli
discov
coronaviru
name
due
similar
gene
sequenc
sever
acut
respiratori
syndrom
coronaviru
sarscov
jan
declar
epidem
public
health
emerg
intern
concern
order
control
epidem
time
multipl
activ
measur
taken
wuhan
worst
epidem
area
china
includ
central
commun
quarantin
recruit
design
hospit
establish
modul
hospit
epidem
preliminari
control
wuhan
china
current
strengthen
support
central
local
govern
howev
confirm
case
worldwid
exceed
mar
mani
countri
itali
iran
spain
unit
state
america
howev
show
ongo
outbreak
inevit
bring
shortag
medic
resourc
accord
report
yang
et
al
mortal
group
critic
ill
patient
mani
patient
mild
symptom
present
sudden
progress
sever
critic
ill
henc
identifi
simpl
effici
predictor
vital
us
provid
strengthen
attent
treatment
target
patient
thu
reduc
mortal
similar
sar
critic
patient
present
higher
plasma
level
cytokin
suggest
involv
inflammatori
storm
pathogenesi
diseas
progress
creactiv
protein
crp
routin
measur
inflammatori
marker
increas
patient
associ
diseas
sever
swedish
multicent
studi
crp
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
suggest
simpl
earli
marker
prognosi
intens
care
unit
icu
admiss
sepsi
admiss
crp
level
mgl
found
associ
increas
icu
mortal
date
prognost
valu
crp
test
patient
retrospect
studi
aim
evalu
potenti
crp
outcom
predict
patient
retrospect
singlecent
studi
conduct
eastern
campu
renmin
hospit
wuhan
univers
jan
feb
eastern
campu
requisit
design
hospit
jan
began
admit
patient
jan
remodel
adult
patient
clinic
outcom
die
recov
till
feb
recruit
studi
patient
without
crp
detect
admiss
exclud
confirm
patient
accord
guidanc
issu
nhc
studi
approv
ethic
committe
renmin
hospit
wuhan
univers
approv
number
wdrm
written
consent
requir
retrospect
charact
studi
inform
patient
obtain
mainli
screen
electron
health
record
laboratori
inform
manag
system
provid
dhc
softwar
co
ltd
beij
china
nurs
record
also
review
necessari
epidemiolog
inform
gender
age
chronic
diseas
histori
smoke
drink
review
assess
well
day
ill
onset
hospit
diseas
sever
admiss
result
laboratori
test
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
admiss
collect
evalu
includ
complet
blood
cell
count
neutrophil
lymphocyt
ratio
nlr
system
inflammatori
index
sii
defin
platelet
count
multipli
nlr
crp
procalcitonin
ddimer
diseas
sever
ordinari
sever
critic
determin
accord
guidanc
issu
nhc
primari
endpoint
clinic
outcom
death
recoveri
secondari
endpoint
diseas
sever
admiss
categor
variabl
present
number
compar
chisquar
test
normal
distribut
continu
variabl
evalu
kolmogorovsmirnov
test
normal
nonnorm
distribut
continu
paramet
describ
mean
standard
deviat
sd
median
interquartil
rang
iqr
compar
independ
test
mannwhitney
test
respect
multivari
logist
regress
conduct
identifi
independ
risk
factor
studi
endpoint
accuraci
independ
predictor
determin
area
receiv
oper
characterist
roc
curv
auc
feb
patient
clinic
outcom
among
exclud
due
lack
crp
data
admiss
henc
patient
final
enrol
studi
includ
case
ordinari
ill
case
sever
critic
ill
admiss
eight
four
patient
die
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
recov
male
femal
median
age
year
one
hundr
thirtyf
patient
chronic
diseas
case
hypertens
case
cerebrovascular
diseas
case
diabet
case
coronari
heart
diseas
case
chronic
pulmonari
diseas
case
cirrhosi
case
anemia
patient
die
male
age
year
chronic
diseas
twentyon
patient
histori
smoke
histori
drink
median
time
onset
symptom
hospit
admiss
day
signific
differ
exist
histori
smoke
drink
day
ill
onset
hospit
survivor
nonsurvivor
nonsurvivor
show
significantli
higher
white
blood
cell
neutrophil
count
nlr
sii
crp
procalcitonin
ddimer
lower
red
blood
cell
lymphocyt
platelet
count
compar
survivor
tabl
independ
predictor
identifi
risk
factor
relat
advers
clinic
outcom
logist
regress
model
indic
tabl
age
neutrophil
count
platelet
count
crp
found
independ
predictor
advers
outcom
hosmer
lemeshow
test
show
good
model
adequaci
determin
compar
accuraci
factor
advers
outcom
predict
roc
curv
analysi
perform
differ
auc
test
figur
auc
crp
significantli
higher
age
neutrophil
count
z
p
platelet
count
z
p
advers
outcom
predict
cutoff
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ill
onset
admiss
median
day
vs
day
p
rais
white
blood
cell
count
median
l
vs
l
p
neutrophil
count
retrospect
studi
age
neutrophil
count
platelet
count
crp
verifi
independ
outcom
predictor
patient
age
neutrophil
count
crp
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
identifi
independ
discrimin
diseas
sever
admiss
import
biomark
infect
critic
ill
includ
nlr
sii
procalcitonin
ddimer
found
associ
clinic
outcom
diseas
sever
howev
none
identifi
independ
predictor
find
studi
suggest
crp
perform
better
three
paramet
predict
advers
outcom
patient
besid
admiss
serum
crp
level
identifi
moder
discrimin
diseas
sever
knowledg
studi
present
first
report
prognost
valu
crp
patient
patholog
mechan
fulli
uncov
studi
median
age
nonsurvivor
year
significantli
higher
year
survivor
age
independ
predictor
advers
outcom
discrimin
severecrit
ill
suggest
old
peopl
vulner
like
develop
severecrit
diseas
elev
neutrophil
count
observ
patient
sever
ill
compar
nonsever
ill
studi
admiss
neutrophil
count
moder
predictor
clinic
outcom
diseas
sever
result
impli
factor
contribut
rais
neutrophil
count
secondari
infect
excess
inflammatori
stress
glucocorticoid
use
might
exacerb
diseas
progress
patient
reduct
peripher
lymphocyt
count
commonli
observ
patient
consid
possibl
critic
factor
associ
diseas
sever
mortal
reduc
cell
count
accompani
overactiv
might
contribut
impair
immun
diseas
progress
patient
studi
signific
discrep
observ
lymphocyt
count
patient
differ
outcom
diseas
sever
nlr
inflammatori
index
defin
neutrophil
count
divid
lymphocyt
count
found
associ
sepsi
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
multipl
organ
damag
recent
prospect
studi
suggest
nlr
earli
predictor
progress
sever
ill
howev
power
nlr
outcom
predict
determin
due
followup
final
outcom
retrospect
studi
rais
nlr
found
nonsurvivor
compar
survivor
associ
diseas
sever
admiss
howev
result
multivari
logist
regress
reveal
neither
lymphocyt
count
nlr
independ
predictor
advers
outcom
discrimin
severecrit
ill
one
distinct
acut
phase
reactant
crp
increas
rapidli
onset
inflamm
cell
damag
tissu
injuri
pulmonari
diseas
inflammatori
featur
usual
rais
serum
crp
level
respons
inflammatori
cytokin
henc
markedli
elev
serum
crp
level
nonsurvivor
patient
severecrit
ill
studi
indic
excess
inflammatori
respons
consist
rais
serum
proinflammatori
cytokin
observ
patient
role
crp
case
diseas
may
involv
host
defens
inflamm
respons
inflammatori
onset
crp
bind
pathogen
promot
elimin
phagocyt
cell
function
first
line
innat
host
defens
besid
crp
exhibit
antiinflammatori
effect
inhibit
neutrophil
chemotaxi
howev
upregul
express
adhes
molecul
proinflammatori
crp
also
exert
proinflammatori
effect
controversi
result
serum
crp
level
observ
patient
acut
lung
injuri
ali
acut
respiratori
distress
syndrom
ard
associ
high
serum
crp
level
favor
outcom
found
adult
patient
aliard
elderli
patient
ali
howev
high
serum
crp
level
correl
higher
mortal
consist
find
patient
direct
attack
organ
damag
caus
excess
inflammatori
respons
might
respons
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
second
patient
critic
ill
admit
intens
care
unit
due
shortag
resourc
undoubtedli
neg
impact
outcom
patient
third
patient
recruit
consecut
due
exclus
case
without
serum
crp
detect
admiss
might
bring
select
bia
fourth
serum
crp
level
correl
degre
inflammatori
respons
therefor
chang
crp
time
might
provid
inform
diseas
prognosi
howev
continu
crp
valu
time
includ
studi
sinc
design
explor
potenti
admiss
crp
outcom
predict
conclus
result
suggest
admiss
serum
crp
level
perform
well
discrimin
diseas
sever
predict
advers
outcom
patient
patient
markedli
elev
admiss
crp
provid
attent
strengthen
treatment
find
singlecent
studi
need
valid
multicent
research
larger
sampl
thank
patient
famili
involv
studi
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
fund
author
declar
compet
interest
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
red
blood
cell
count
hemoglobin
present
mean
sd
compar
independ
test
nonsurvivor
survivor
continu
variabl
present
median
iqr
compar
mannwhitney
test
chisquar
test
conduct
compar
categor
variabl
two
group
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
receiv
oper
characterist
roc
curv
age
neutrophil
count
platelet
count
creactiv
protein
advers
outcom
predict
area
curv
auc
age
neutrophil
count
platelet
count
creactiv
protein
predict
advers
outcom
respect
auc
creactiv
protein
significantli
higher
age
neutrophil
count
z
p
platelet
count
z
p
advers
outcom
predict
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
